Skip to main content
RAPS Euro Convergence 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed Event
Ticketed Event
Sponsored Presentation
Sponsored Presentation
Learning Level: Foundational
Learning Level: Foundational
New Exhibitor
New Exhibitor
Networking Event
Networking Event
Enterprise Network Member
Enterprise Network Member
Learning Level: Expert
Learning Level: Expert
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Intermediate
Learning Level: Intermediate

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Monday, May 6, 2024
  • 07:30 – 18:00 CEST
    Cloakroom
  • 07:30 – 18:00 CEST
    Registration Hours
  • 08:30 – 16:00 CEST
    Pre -Conference Workshop: EUDAMED
  • 08:30 – 16:00 CEST
    Pre-Conference Workshop: Artificial Intelligence knocking on your door? The upcoming Artificial Intelligence Regulation’s Technical Documentation Requirements and how to integrate them into an MDR Submission
  • 08:30 – 16:00 CEST
    Pre-Conference Workshop: Global Regulatory CMC Approaches for Biologicals: From Strategy to Execution
  • 08:30 – 16:00 CEST
    Pre-Conference Workshop: IVDR Technical Documentation
  • 08:30 – 16:00 CEST
    Pre-Conference Workshop: Start-Ups: Effective Use of the Money of Your Investors - Know What to Aim For
  • 08:30 – 16:00 CEST
    Pre-Conference Workshop: What does it take from CE to MDSAP?
  • 13:00 – 17:00 CEST
    Speaker Ready Room Open (B04)
  • 14:00 – 16:00 CEST
    Career Development for Students
  • 16:30 – 18:30 CEST
    Euro Convergence 2024 Welcome & Opening Plenary : Regulatory Affairs: Science or Art?
  • 18:30 – 19:30 CEST
    Opening Reception in Exhibit Hall
  • Tuesday, May 7, 2024
  • 07:30 – 18:00 CEST
    Registration Hours
  • 07:30 – 18:00 CEST
    Speaker Ready Room Open (B04)
  • 08:30 – 09:30 CEST
    Biocompatibility: ‘Substances of concern’ – Have you checked? GSPR 10.4 a practical guide
  • 08:30 – 09:30 CEST
    Development and Registration of Therapeutic Radiopharmaceuticals in the EU - Navigating Opportunities and Challenges
  • 08:30 – 09:30 CEST
    Kick-off MDR panel
  • 08:30 – 09:30 CEST
    Patient Access
  • 08:30 – 09:30 CEST
    The EU’s AI Act: Understanding the challenges to AI-enabled Medical Devices conformity assessments .
  • 08:30 – 09:30 CEST
    The IVDR clock is ticking... but should there be alarm?
  • 09:45 – 16:45 CEST
    Exhibition Open
  • 09:50 – 10:50 CEST
    Artificial Intelligence in the context of the IVDR – How to keep the revolution under control.
  • 09:50 – 10:50 CEST
    Clinical Evaluation
  • 09:50 – 10:50 CEST
    Clinical Performance Studies under IVDR
  • 09:50 – 10:50 CEST
    Emerging Advancements in eCTD: A Panel Discussion on Cloud Integration, Data Standards, and Publishing Perspectives in Regulatory Submissions
  • 09:50 – 10:50 CEST
    New EU Pharma Legislation
  • 09:50 – 10:50 CEST
    Regulatory Leadership: Digitization & Digital Health - There is NO turning back!
  • 10:50 – 11:30 CEST
    Presenters at Posters (C Level)
  • 10:50 – 11:30 CEST
    Refreshment Break in Exhibit Area on all Levels
  • 11:30 – 12:00 CEST
    Global IVDs
  • 11:30 – 12:30 CEST
    Career Development: Forging a Career Path in the Age of Technology
  • 11:30 – 12:30 CEST
    Key trends impacting HTA and Regulatory interface
  • 11:30 – 12:30 CEST
    The MDR and The AI Act: A Match Made in Heaven or The Odd Couple?
  • 11:30 – 12:30 CEST
    The MDR hurdle for startups and innovation - and strategies to overcome it
  • 11:30 – 12:30 CEST
    UKCA
  • 12:00 – 12:30 CEST
    Global IVDs
  • 12:30 – 13:00 CEST
    SESSION IS FULL: Solutions Circle: RA-GPT – The Future of the Regulatory Profession
  • 12:30 – 13:00 CEST
    Solution Circle: The Time is Now: The Journey to Becoming RCC Certified!
  • 12:30 – 13:00 CEST
    Solution Circle: What can manufacturers learn from effective PMS/PMPF strategies to strengthen their Clinical Evidence with the IVDR transition deadline approaching?
  • 12:30 – 13:45 CEST
    Chapter/Local Networking Group Meet and Greets
  • 12:30 – 13:45 CEST
    Networking Lunch in Exhibit Hall on all Levels
  • 13:00 – 13:30 CEST
    Sponsored Presentation: 3 Changes Affecting MedTech Regulatory Teams
  • 13:00 – 13:30 CEST
    Sponsored Presentation: How to accelerate global market entry and to reduce time-to-market? A Notified/Certification body perspective
  • 13:00 – 13:30 CEST
    Sponsored Presentation: Objective-driven systems: How to build effective and continuous Regulatory Intelligence and Clinical Surveillance
  • 13:00 – 13:30 CEST
    Sponsored Presentations Purdie Pascoe: PMCF Surveys: from plan to action
  • 13:00 – 13:30 CEST
    Sponsored Presentations QbD Group: Transitional provisions of the IVDR - Can I sit back and relax?
  • 13:00 – 13:30 CEST
    Sponsored Presentations RIMSYS: Clearing up EUDAMED confusion for medtech regulatory teams
  • 13:15 – 13:45 CEST
    SESSION IS FULL Repeat: Solutions Circle: RA-GPT – The Future of the Regulatory Profession
  • 13:15 – 13:45 CEST
    Solution Circle: How to distinguish general and specific PMCF activities
  • 13:15 – 13:45 CEST
    Solution Circle: Post-Market Surveillance (PMS) and Post-Market Performance Follow-up (PMPF) according to the IVDR
  • 13:45 – 14:45 CEST
    Finding value in post market clinical data collection
  • 13:45 – 14:45 CEST
    IVDR Class D Devices – Latest Updates & Experience
  • 13:45 – 14:45 CEST
    Meeting EMA and FDA: Formal and informal pathways, in search of alignment
  • 13:45 – 14:45 CEST
    Randomized Clinical Trials vs. Validation Cohort studies of AI/ML-based SaMDs: what are the differences and guidelines for appraisal of the clinical evidence?
  • 13:45 – 14:45 CEST
    The future of standardization in Medtech and its impact on your regulatory compliance
  • 13:45 – 14:45 CEST
    Unveiling Insights: Navigating the public disclosure of clinical trials in an evolving industry
  • 15:05 – 16:05 CEST
    CDx or not CDx that is the Question
  • 15:05 – 16:05 CEST
    From China to WHO: Strategies and Updates to Accelerate China and WHO Drug Approvals and Master Files
  • 15:05 – 16:05 CEST
    MDR Art. 117 for Combination Products. Are the challenges solved now? State of Play from EMA, NB and Industry
  • 15:05 – 16:05 CEST
    Post-market requirements: Keeping PSUR and SSCP up to date
  • 15:05 – 16:05 CEST
    Securing AI solutions in MedTech products
  • 15:05 – 16:05 CEST
    Use of Real World Evidence
  • 16:05 – 16:45 CEST
    Coffee Break in the Exhibit Hall on all Levels
  • 16:05 – 16:45 CEST
    Presenters at Posters (C Level)
  • 16:10 – 16:40 CEST
    Sponsored Presentation: How It Works: Your Questions About Notified Bodies & Testing Houses Answered
  • 16:10 – 16:40 CEST
    Sponsored Presentation: Leveraging AI for Successful Clinical Evaluation and PMCF Strategies
  • 16:10 – 16:40 CEST
    Sponsored Presentation: MDR has come: A call for a proactive boost in Medtech Innovation Industry
  • 16:10 – 16:40 CEST
    Sponsored Presentation: Regulatory Intelligence: From information overload to strategic decision-making
  • 16:10 – 16:40 CEST
    Sponsored Presentation: Regulatory Transformation: Leveraging AI & Digital Transformation to Enable Regulatory Excellence
  • 16:10 – 16:40 CEST
    Sponsored Presentation: Using Clock Stops Wisely to Appropriately Address CHMP Issues – Why Time Matters
  • 16:45 – 17:45 CEST
    Don’t get orphaned: how to be novel in the IVDR environment.
  • 16:45 – 17:45 CEST
    EMA Scientific Advice for high-risk devices – What we know so far
  • 16:45 – 17:45 CEST
    Importance of New Active Substance status for biologics, and CMC strategies for development of C&G therapies
  • 16:45 – 17:45 CEST
    Navigating the future: Embracing AI and ChatGPT in Regulatory Affairs and Quality Management for Pharma and MedTech Professionals alike
  • 16:45 – 17:45 CEST
    Pre-clinical evaluations and clinical investigations. Strategizing towards efficiency and new approaches including in silico methods
  • 16:45 – 17:45 CEST
    Regulators and Industry perspective on Use of Artificial Intelligence in the Drug Development Lifecycle
  • 18:30 – 22:30 CEST
    Networking Dinner (ticket required): Spreespeicher Event (Stralauer Allee 2)
  • Wednesday, May 8, 2024
  • 07:30 – 15:30 CEST
    Speaker Ready Room Open (B04)
  • 07:30 – 16:00 CEST
    Registration Hours
  • 07:30 – 17:00 CEST
    Cloakroom
  • 08:30 – 09:45 CEST
    Conversations That Matter: Interactions with Health Authorities
  • 09:45 – 10:25 CEST
    Coffee Break in the Exhibit Hall on all Levels
  • 09:45 – 10:25 CEST
    Presenters at Posters (C Level)
  • 09:45 – 15:45 CEST
    Exhibition Open
  • 10:25 – 11:25 CEST
    Application of article 61(10), non-clinical data, for SaMD and AI
  • 10:25 – 11:25 CEST
    Career Development: LIVE LinkedIn review Session
  • 10:25 – 11:25 CEST
    CTA with Devices
  • 10:25 – 11:25 CEST
    Global IVDs
  • 10:25 – 11:25 CEST
    Risk Management
  • 10:25 – 11:25 CEST
    The paradigm shift in the EU market approval of devices and IVDs - a hot potato?!
  • 11:45 – 12:45 CEST
    Clinical Evaluation
  • 11:45 – 12:45 CEST
    Data Security & Digital Health
  • 11:45 – 12:45 CEST
    Environmental Regulation
  • 11:45 – 12:45 CEST
    Maintaining Compliance: IVDR Post-Certification Activities
  • 11:45 – 12:45 CEST
    Patient-Centric Endpoints and Use of Digital Health Technologies
  • 11:45 – 12:45 CEST
    Supply Chain/Shortage
  • 12:45 – 13:15 CEST
    SESSION IS FULL Circle: Essentials of EU Regulatory Intelligence; Overview of Key Aspects of Regulatory Intelligence
  • 12:45 – 13:15 CEST
    Solution Circle: Cyber Security – Pitfalls for IVDR Technical File Submission
  • 12:45 – 13:15 CEST
    Solution Circle: How does the SSCP improve patient safety in less than 100 pages?
  • 12:45 – 14:00 CEST
    Chapter/Local Networking Group Meet and Greets (C Level)
  • 12:45 – 14:00 CEST
    Networking Lunch in Exhibit Hall on all Levels
  • 13:15 – 13:45 CEST
    Sponsored Presentation: Consolidating Economic Operators for Market Access Globally
  • 13:15 – 13:45 CEST
    Sponsored Presentation: Navigating The Future - Insights From The 2024 State Of Medtech Report
  • 13:15 – 13:45 CEST
    Sponsored Presentation: Raising the Bar on Cybersecurity: Understanding New Regulations and How IEC 81001-5-1 can Help Navigate
  • 13:15 – 13:45 CEST
    Sponsored Presentation: State of the art and the medical device lifecycle
  • 13:15 – 13:45 CEST
    Sponsored Presentation: The challenge of the transition: a practical guide on how to use data historicity to produce correct rationales and deal effectively with the transition from MDD to MDR
  • 13:15 – 13:45 CEST
    Sponsored Presentation: The top gotchas when expanding your clinical development into the US
  • 13:30 – 14:00 CEST
    Solution Circle: Effective Strategies When Approaching Regulatory Due Diligence under the MDR
  • 13:30 – 14:00 CEST
    Solution Circle: Intended purpose, device classification, NB codes and corresponding types of devices /sampling TD under the IVDR
  • 13:30 – 14:00 CEST
    Solution Circle:Effective Strategies for High-Quality Clinical Data Collection through Post-market Clinical Follow-Up (PMCF) Surveys and Medical Device Registries
  • 14:00 – 15:00 CEST
    International Regulatory Frameworks to Accelerate Orphan Drug Registrations
  • 14:00 – 15:00 CEST
    Core Data Sheets
  • 14:00 – 15:00 CEST
    Cybersecurity
  • 14:00 – 15:00 CEST
    Experience gain from implementing Article 5(5) of the IVDR in a network of European Laboratories
  • 14:00 – 15:00 CEST
    IMDRF Coding
  • 14:00 – 15:00 CEST
    Post Market Clinical Studies
  • 15:00 – 15:40 CEST
    Coffee Break in the Exhibit Hall
  • 15:00 – 15:40 CEST
    Presenters at Posters (C Level)
  • 15:40 – 16:40 CEST
    An overview of AI, Software and Cybersecurity regulations in Asia
  • 15:40 – 16:40 CEST
    Blood, Sweat and Tears - Biologics and their Challenges
  • 15:40 – 16:40 CEST
    IVDR Track Closing Panel: What Are The Remaining Challenges for IVDR?
  • 15:40 – 16:40 CEST
    Orphan Devices
  • 15:40 – 16:40 CEST
    Regulatory Intelligence and Policy Strategy; Dynamic Regulatory Assessment as a case study
  • 15:40 – 16:40 CEST
    Structured Dialogue
  • 16:40 – 17:15 CEST
    Closing Remarks & Farewell Toast